Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10415157rdf:typepubmed:Citationlld:pubmed
pubmed-article:10415157lifeskim:mentionsumls-concept:C0004112lld:lifeskim
pubmed-article:10415157lifeskim:mentionsumls-concept:C0289174lld:lifeskim
pubmed-article:10415157lifeskim:mentionsumls-concept:C1442792lld:lifeskim
pubmed-article:10415157lifeskim:mentionsumls-concept:C0205217lld:lifeskim
pubmed-article:10415157lifeskim:mentionsumls-concept:C1521733lld:lifeskim
pubmed-article:10415157lifeskim:mentionsumls-concept:C0597360lld:lifeskim
pubmed-article:10415157lifeskim:mentionsumls-concept:C0870432lld:lifeskim
pubmed-article:10415157lifeskim:mentionsumls-concept:C1705417lld:lifeskim
pubmed-article:10415157lifeskim:mentionsumls-concept:C1555465lld:lifeskim
pubmed-article:10415157lifeskim:mentionsumls-concept:C1879547lld:lifeskim
pubmed-article:10415157pubmed:issue2lld:pubmed
pubmed-article:10415157pubmed:dateCreated1999-8-24lld:pubmed
pubmed-article:10415157pubmed:abstractTextIn human brain tissues from patients dying with cerebral infarction, hypertensive encephalopathy, Alzheimer's disease, Huntington's disease, frontotemporal dementia, and Creutzfeldt-Jakob disease there is an activation of astrocytes. Such activated astrocytes display GFAP and strong 5-HT(2A), but not 5-HT(2B) or 5-HT(2C), receptor immunoreactivity; this 5-HT(2A) reaction has not been observed in normal, nonactivated astrocytes. It is suggested that an up-regulation of 5-HT(2A) receptors may be part of an early response reaction in astrocytes, possibly designed to maintain homeostasis or to induce secondary message pathways involving trophic factors or glycogenolysis.lld:pubmed
pubmed-article:10415157pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10415157pubmed:languageenglld:pubmed
pubmed-article:10415157pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10415157pubmed:citationSubsetIMlld:pubmed
pubmed-article:10415157pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10415157pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10415157pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10415157pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10415157pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10415157pubmed:statusMEDLINElld:pubmed
pubmed-article:10415157pubmed:monthAuglld:pubmed
pubmed-article:10415157pubmed:issn0014-4886lld:pubmed
pubmed-article:10415157pubmed:authorpubmed-author:KumarSSlld:pubmed
pubmed-article:10415157pubmed:authorpubmed-author:WuCClld:pubmed
pubmed-article:10415157pubmed:authorpubmed-author:SinghS KSKlld:pubmed
pubmed-article:10415157pubmed:authorpubmed-author:MannD MDMlld:pubmed
pubmed-article:10415157pubmed:authorpubmed-author:DiabAAlld:pubmed
pubmed-article:10415157pubmed:copyrightInfoCopyright 1999 Academic Press.lld:pubmed
pubmed-article:10415157pubmed:issnTypePrintlld:pubmed
pubmed-article:10415157pubmed:volume158lld:pubmed
pubmed-article:10415157pubmed:ownerNLMlld:pubmed
pubmed-article:10415157pubmed:authorsCompleteYlld:pubmed
pubmed-article:10415157pubmed:pagination529-33lld:pubmed
pubmed-article:10415157pubmed:dateRevised2009-9-29lld:pubmed
pubmed-article:10415157pubmed:meshHeadingpubmed-meshheading:10415157...lld:pubmed
pubmed-article:10415157pubmed:meshHeadingpubmed-meshheading:10415157...lld:pubmed
pubmed-article:10415157pubmed:meshHeadingpubmed-meshheading:10415157...lld:pubmed
pubmed-article:10415157pubmed:meshHeadingpubmed-meshheading:10415157...lld:pubmed
pubmed-article:10415157pubmed:meshHeadingpubmed-meshheading:10415157...lld:pubmed
pubmed-article:10415157pubmed:meshHeadingpubmed-meshheading:10415157...lld:pubmed
pubmed-article:10415157pubmed:meshHeadingpubmed-meshheading:10415157...lld:pubmed
pubmed-article:10415157pubmed:meshHeadingpubmed-meshheading:10415157...lld:pubmed
pubmed-article:10415157pubmed:meshHeadingpubmed-meshheading:10415157...lld:pubmed
pubmed-article:10415157pubmed:meshHeadingpubmed-meshheading:10415157...lld:pubmed
pubmed-article:10415157pubmed:meshHeadingpubmed-meshheading:10415157...lld:pubmed
pubmed-article:10415157pubmed:meshHeadingpubmed-meshheading:10415157...lld:pubmed
pubmed-article:10415157pubmed:meshHeadingpubmed-meshheading:10415157...lld:pubmed
pubmed-article:10415157pubmed:meshHeadingpubmed-meshheading:10415157...lld:pubmed
pubmed-article:10415157pubmed:meshHeadingpubmed-meshheading:10415157...lld:pubmed
pubmed-article:10415157pubmed:meshHeadingpubmed-meshheading:10415157...lld:pubmed
pubmed-article:10415157pubmed:meshHeadingpubmed-meshheading:10415157...lld:pubmed
pubmed-article:10415157pubmed:meshHeadingpubmed-meshheading:10415157...lld:pubmed
pubmed-article:10415157pubmed:year1999lld:pubmed
pubmed-article:10415157pubmed:articleTitleActivated astrocytes display increased 5-HT2a receptor expression in pathological states.lld:pubmed
pubmed-article:10415157pubmed:affiliationDepartment of Pathological Sciences, University of Manchester, Oxford Road, Manchester, M13 9PT, United Kingdom.lld:pubmed
pubmed-article:10415157pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10415157pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10415157lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10415157lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10415157lld:pubmed